324 related articles for article (PubMed ID: 35563253)
1. The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease.
Wiatrak B; Balon K; Jawień P; Bednarz D; Jęśkowiak I; Szeląg A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563253
[TBL] [Abstract][Full Text] [Related]
2. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
3. d-glutamate and Gut Microbiota in Alzheimer's Disease.
Chang CH; Lin CH; Lane HY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290475
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology.
Dhanawat M; Malik G; Wilson K; Gupta S; Gupta N; Sardana S
CNS Neurol Disord Drug Targets; 2024 Jul; ():. PubMed ID: 38967078
[TBL] [Abstract][Full Text] [Related]
5. Time to test antibacterial therapy in Alzheimer's disease.
Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control.
Li J; Zhang F; Zhao L; Dong C
Rev Neurosci; 2023 Aug; 34(6):695-718. PubMed ID: 37076953
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
Lipton SA
Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
[TBL] [Abstract][Full Text] [Related]
10. Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
Wang Y; Dykes GA
CNS Neurol Disord Drug Targets; 2022; 21(1):14-25. PubMed ID: 34365962
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota-gut-brain axis.
Ma L; Jiang X; Huang Q; Chen W; Zhang H; Pei H; Cao Y; Wang H; Li H
Biomed Pharmacother; 2023 Sep; 165():115244. PubMed ID: 37516021
[TBL] [Abstract][Full Text] [Related]
12. The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review.
Aaldijk E; Vermeiren Y
Ageing Res Rev; 2022 Mar; 75():101556. PubMed ID: 34990844
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
Standridge JB
Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
[TBL] [Abstract][Full Text] [Related]
14. Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies.
Seo DO; Holtzman DM
Exp Mol Med; 2024 Feb; 56(1):86-94. PubMed ID: 38172602
[TBL] [Abstract][Full Text] [Related]
15. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
17. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?
Esposito Z; Belli L; Toniolo S; Sancesario G; Bianconi C; Martorana A
CNS Neurosci Ther; 2013 Aug; 19(8):549-55. PubMed ID: 23593992
[TBL] [Abstract][Full Text] [Related]
18. Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation.
Lekchand Dasriya V; Samtiya M; Dhewa T; Puniya M; Kumar S; Ranveer S; Chaudhary V; Vij S; Behare P; Singh N; Aluko RE; Puniya AK
J Food Biochem; 2022 Jan; 46(1):e14043. PubMed ID: 34927261
[TBL] [Abstract][Full Text] [Related]
19. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota is an Impact Factor based on the Brain-Gut Axis to Alzheimer's Disease: A Systematic Review.
Zou B; Li J; Ma RX; Cheng XY; Ma RY; Zhou TY; Wu ZQ; Yao Y; Li J
Aging Dis; 2023 Jun; 14(3):964-1678. PubMed ID: 37191418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
